Anew Medical, Inc.
Anew Medical, Inc., a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors. The company has a strategic par… Read more
Anew Medical, Inc. (WENA) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2024: 0.274x
Based on the latest financial reports, Anew Medical, Inc. (WENA) has a cash flow conversion efficiency ratio of 0.274x as of June 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-424.86K) by net assets ($-1.55 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Anew Medical, Inc. - Cash Flow Conversion Efficiency Trend (2021–2023)
This chart illustrates how Anew Medical, Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Anew Medical, Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Anew Medical, Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Quantum Genomics SA
PA:ALQGC
|
3.110x |
|
NeoTerrex Minerals Inc.
V:NTX
|
N/A |
|
Dave Inc. Warrants
NASDAQ:DAVEW
|
0.286x |
|
Ikapharmindo Putramas Tbk.
JK:IKPM
|
-0.005x |
|
Prg Holdings Bhd
KLSE:7168
|
-0.006x |
|
Tincorp Metals Inc.
OTCQX:TINFF
|
-0.007x |
|
ZYTRONIC PLC LS-01
F:8HD
|
N/A |
|
Norwest Minerals Ltd
AU:NWM
|
-0.015x |
Annual Cash Flow Conversion Efficiency for Anew Medical, Inc. (2021–2023)
The table below shows the annual cash flow conversion efficiency of Anew Medical, Inc. from 2021 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | $11.21 Million | $-1.26 Million | -0.113x | -2487.80% |
| 2022-12-31 | $113.32 Million | $-493.04K | -0.004x | +98.43% |
| 2021-12-31 | $1.03 Million | $-284.02K | -0.277x | -- |